In addition, the activities of serum ALT and AST were significantly increased in T2DM rats compared with rats in the Control group (p < 0.01, respectively), and the activities of serum ALT and AST were significantly decreased in Metformin (p < 0.01, respectively), PDJQ middle-dose (p < 0.05 and p < 0.01, respectively) and PDJQ high-dose groups (p < 0.01, respectively) compared with those in T2DM group (Table 2). The gene discussed is GPT; the disease is type 2 diabetes mellitus.